Virtual Reality Headset and/or Aromatherapy for Patients Undergoing a Transperineal Prostate Biopsy
Part of paid clinical trials in Pittsburgh, Pennsylvania.
- Sponsor
- University of Pittsburgh
- Study ID
- NCT06296147
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- MALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Virtual Reality Headset — OTHERThe interventions are for supportive care ONLY.
- Aromatherapy Patch — OTHERThe interventions are for supportive care ONLY.
- Standard of Care — OTHERParticipant will undergo a transperineal prostate biopsy.
Study Details
The purpose of this study is to evaluate if a VR headset and/or aromatherapy can be used to reduce patient pain, anxiety, and embarrassment during a transperineal biopsy (TPBx) compared to standard of care (SOC). The primary objective is to evaluate differences in self-reported pain, fear, or embarrassment during and after the procedure between the VR Group, Aromatherapy Group, VR+Aromatherapy Group, and the Control group.
Key Dates
- Start date
- May 20, 2024
- Status verified
- Jan 2026
- Primary completion
- May 1, 2026
- Completion
- May 1, 2026
Study Design
- Enrollment
- 208 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Virtual Reality DeviceThe VR device used is the Flowly biofeedback virtual headset. This device uses calming immersive virtual worlds along with breathing exercises and a heart rate monitor to guide patients through meditated breathing exercises. The Flowly app is based on a smartphone which will be purchased through the department and used by all participants. The account used is a generic account for our department. No patient information or individualized accounts will be needed. No patient information or data will be collected.
- Experimental: AromatherapyThe aromatherapy arm will utilize one standardized patch with a peppermint/lavender scent based on prior research and experience.
- Experimental: Virtual Reality and AromatherapyThis arm will combine both the Virtual Reality arm and the aromatherapy arm procedure.
- Active Comparator: Standard of CareParticipant will undergo transperineal prostate biopsy as standard of care.
Primary Outcome Measure
Levels of pain, fear, and embarrassment that each group experienced before the TPBx measured using a self-reported survey that asks about experience prior to biopsy. The survey will be provided after the procedure. [ Time Frame: immediately after the biopsy (up to 30 minutes) ]
Central Contacts
- Divya Natesan(412) 692-4100
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Pittsburgh Medical Center Shadyside Hospital | Pittsburgh | Pennsylvania | 15232 | Divya Natesan, BS John Myrga, MD Bruce Jacobs, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Pittsburgh, PA
Related Studies
- A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical StudyPHASE2 · Recruiting · Astellas Pharma Global Development, Inc. · Anchorage, Alaska
- International Registry for Men With Advanced Prostate Cancer (IRONMAN)Recruiting · Prostate Cancer Clinical Trials Consortium · Birmingham, Alabama
- The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac StudyRecruiting · UMC Utrecht · Pittsburgh, Pennsylvania
- Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate CancerPHASE1 · Recruiting · Amgen · Duarte, California